caladrius biosciences inc
(CLBS:Consolidated Issue listed on NASDAQ Capital Market)
Alan G. Harris M.D., Ph.D., FACP FRCP
|Age||Total Calculated Compensation||This person is connected to 0 board members in 1 different organizations across 4 different industries.|
Dr. Alan G. Harris, M.D. Ph.D. FACP FRCP serves as an Officer of Ophthalmic Imaging Systems Inc. Dr. Harris served as Vice President of Regenerative Medicine Drug Development and Regulatory Affairs at Caladrius Biosciences, Inc. (formerly Neostem Inc.) since July 2009. Dr. Harris served as Chief Medical Officer of Immune Pharmaceuticals Corp. since September 2011. Dr. Harris was responsible to develop Bertilimumab, company's phase II ready fully human monoclonal antibody ...
420 Lexington AvenuePhone: 212-584-4180
New York, New York 10170
Board Members Memberships*There is no Board Members Memberships data available.
Université de Strasbourg
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|